Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 36, 2006 - Issue 1
274
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Plant polyphenols and multidrug resistance: Effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models

, , , , &
Pages 41-58 | Received 20 Jun 2005, Published online: 22 Sep 2008

References

  • Arts ICW, Van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in the Netherlands. 2. tea, wine, fruit juices, and chocolate milk. Journal of Agricultural Food Chemistry 2000; 48: 1752–1757
  • Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery 2001; 46: 27–43
  • Augustijns PF. Uptake and transport characteristics of chloroquine in an in-vitro cell culture system of the intestinal mucosa, Caco-2. Journal Pharmacy Pharmacology 1996; 48: 277–280
  • Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, De Hass M, Van Deemter L, Borst P, Varadi A, Sarkadi B. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. Journal of Biological Chemistry 1998; 273: 32167–32175
  • Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Jaillon P, Funck-Brentano C. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clinical Pharmacology and Therapeutics 2001; 70: 311–316
  • Bois F, Beney C, Boumendjel A, Mariotte A-M, Conseil G, Di Pietro A. Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance. Journal of Medicinal Chemistry 1998; 41: 4161–4164
  • Bois F, Boumendjel A, Mariotte A-M, Conseil G, Di Petro A. Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance. Bioorganic Medicinal Chemistry 1999; 7: 2691–2695
  • Bors W, Michel C, Stettmaier K. Antioxidant effects of flavonoids. Biofactors 1997; 6: 399–402
  • Briviba K, Sies H. Nonenzymatic antioxidant defense systems. Natural antioxidants in human health and disease, B Frei. Academic Press, San Diego, CA 1994; 107–128, 1994
  • Casaschi A, Maiyoh GK, Rubio BK, Li RW, Adeli K, Theriault AG. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. Journal of Nutrition 2004; 134: 1340–1346
  • Cavet ME, West M, Simmons NL. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. British Journal of Pharmacology 1996; 118: 1389–1396
  • Cermak R, Föllmer U, Wolffram S. Dietary flavonol quercetin induces chloride secretion in rat colon. American Journal of Physiology 1998; 275: G1166–G1172
  • Chow H-HS, Cai Y, Alberts DS, Hakim I, Dorr RT, Shahi F, Crowell JA, Yang CS, Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiology, Biomarkers, and Prevention 2001; 10: 53–58
  • Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Biochemistry 1998; 95: 9831–9836
  • Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of Adriamycin® accumulation and efflux by flavonoids in HCT-15 colon cells. Biochemical Pharmacology 1994; 48: 1437–1445
  • Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, Lamy S, Bertrand Y, Beliveau R. Green tea catechins as novel antitumor and antiangiogenic compounds. Current Medicinal Chemistry 2002; 2002: 441–463
  • Di Pietro A, Conseil G, Pérez-Victoria JM, Dayan G, Baubichon-Cortay H, Trompier D, Steinfels E, Jault J-M, De H, Maitrejean M, Comte G, Boumendjel A, Mariotte A-M, Dumontet C, McIntosh DB, Goffeau A, Castanys S, Gamarro F, Barron D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cellular Molecular Life Sciences 2002; 59: 307–322
  • Dresser GK, Bailey DG. The effects of fruit juices on drug disposition: A new model for drug interactions. European Journal of Clinical Investigators 2003; 33(Suppl 2)10–16
  • Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical Pharmacology and Therapeutics 2002; 71: 11–20
  • Evers R, Kool M, Van Deemter L, Janssen H, Calafat J, Oomen LCJM, Paulusma CC, Elferink RPJO, Baas F, Schinkel AH, Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. Journal of Clinical Investigations 1998; 101: 1310–1319
  • Evers R, Zaman GJR, Van Deemter L, Jansen H, Calafat J, Oomen LCJM, Elferink RPJO, Borst P, Schinkel AH. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. Journal of Clinical Investigation 1996; 97: 1211–1218
  • Ferté J, Kühnel J-M, Chapuis G, Rolland Y, Lewin G, Schwaller MA. Flavonoid-related modulators of multidrug resistance: Synthesis, pharmacological activity, and structure–activity relationships. Journal of Medicinal Chemistry 1999; 42: 478–489
  • Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf H-R, Frank N, Bartsch H, Becker H. Cancer chemopreventive activity of xanthohumol, a natural product derived from Hop. Molecular Cancer Therapeutics 2002; 1: 959–969
  • Grés M-C, Julian B, Bourrié M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line. Pharmaceutical Research 1998; 15: 726–733
  • Gutmann K, Fricker G, Torok M, Michael S, Beglinger C, Drewe J. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharmaceutical Research 1999; 16: 402–407
  • Henderson MC, Miranda CL, Stevens JF, Deinzer ML, Buhler DR. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000; 30: 235–251
  • Hertog MGL, Hollman PCH, Van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. Journal of Agricultural Food Chemistry 1993; 41: 1242–1246
  • Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 1995; 155: 381–386
  • Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Critical Reviews in Food Science Nutrition 2003; 43: 89–143
  • Hirohashi T, Suzuki H, Chu X-Y, Tamai I, Tsuji A, Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). Journal of Pharmaceutical and Experimental Therapeutics 2000; 292: 265–270
  • Hollman PCH, Katan MB. Bioavailability and health effects of dietary flavonols in man. Archives in Toxicology Suppl. 1997; 20: 237–248
  • Hollman PCH, Katan MB. Dietary flavonoids: Intake, health effects and bioavailability. Food Chemical Toxicology 1999; 37: 937–942
  • Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Journal of Biological Chemistry 1993; 268: 14991–14997
  • Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochimica et Biophysica Acta 2002; 1542: 149–159
  • Kehrer JP, Smith CV. Free radicals in biology: Sources, reactivities, and roles in the etiology of human disease. Natural antioxidants in human health and disease, B Frei. Academic Press, San Diego, CA 1994; 25–62
  • Kuo S-M, Leavitt PS, Lin C-P. Dietary flavonoids interact with trace metals and affect metallonthionein level in human intestinal cells. Biological Trace Element Research 1998; 62: 135–153
  • Louvard D. Apical membrane aminopeptidase appears at site of cell–cell contact in cultured kidney epithelial cells. Proceedings of the National Academy of Sciences,USA 1980; 77: 4132–4136
  • Lowes S, Cavet ME, Simmons NL. Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers. European Journal of Pharmacology 2003; 458: 49–56
  • Mata JE, Miranda CL, Buhler DR, Brown JJ, Rodriguez-Proteau R. Effects of flavonoid treatment on the permeability of cyclosporin A across Caco-2 cell monolayers. Toxicological Sciences 2004, The Toxicologist 78(1-S)
  • Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang Y-H, Deinzer ML, Barnes DW, Buhler DR. Antiproliferative and cytotoxic effects of prenylated flavonoids from Hops (Humulus luplus) in human cancer cell lines. Food and Chemical Toxicology 1999; 37: 271–285
  • Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. Journal of Agricultural Food Chemistry 2000a; 48: 3876–3884
  • Miranda CL, Yang Y-H, Henderson MC, Stevens JF, Santana-Rios G, Deinzer ML, Buhler DR. Prenylflavonoids from HOPS inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4,5-F]quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metabolism and Disposition 2000b; 28: 1297–1302
  • Nakachi K, Matsuyama S, Miyake K, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention. Biofactors 2000; 13: 49–54
  • Pauli-Magnus C, Von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics 2000; 293: 376–382
  • Phang JM, Poore M, Lopaczynska J, Yeh GC. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Research 1993; 53: 5977–5981
  • Sanchez de Medina F, Gálvez J, González M, Zarzuelo A, Barrett KE. Effects of quercetin on epithelial chloride secretion. Life Sciences 1997; 20: 2049–2055
  • Scambia G, Ranelleti FO, Benedetti-Panici P, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Mancuso S. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemotherapy and Pharmacology 1994; 34: 459–464
  • Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted p-glycoprotein. Biochemistry and Pharmacology 1997; 53: 587–596
  • Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharmaceutical Research 1999; 16: 478–485
  • Spencer JPE, Rice-Evans C, Srai SKS. Metabolism in the small intestine and gastrointestinal tract. Flavonoids in health and disease, C Rice-Evans. Marcel Dekker, New York, NY 2003; 363–389
  • Stevens JF, Ivancic M, Hsu V, Deinzer ML. Prenylflavonoids from Humulus lupulus. Phytochemistry 1997; 44: 1575–1585
  • Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: To your good health!. Phytochemistry 2004; 65: 1317–1330
  • Stevens JF, Taylor A, Deinzer ML. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography–tandem mass spectrometry. Journal Chromatography A 1999; 832: 97–107
  • Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. Journal of Pharmacology and Experimental Therapeutics 2001; 299: 164–170
  • Tang F, Horie K, Borchardt RT. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?. Pharmaceutical Research 2002; 19: 773–779
  • Tchamo DN, Dijoux-Franca M-G, Mariotte A-M, Tsamo E, Daskiewicz JB, Bayet C, Barron D, Conseil G, Di Pietro A. Prenylated xanthones as potential P-glycoprotein modulators. Bioorganic and Medicinal Chemistry Letters 2000; 10: 1343–1345
  • Tobe H, Muraki Y, Kitamura K, Komiyama O, Sato Y, Sugioka T, Maruyama HB, Matsuda E, Nagai M. Bone resorption inhibitors from hop extract. Bioscience, Biotechnology and Biochemistry 1997; 61: 158–159
  • Turner NJ, Thomson BM, Shaw IC. Bioactive isoflavones in functional foods: The importance of gut microflora on bioavailability. Nutritional Reviews 2003; 61: 204–213
  • US General Accounting Office. Food safety. Report to Congressional Committees: GAO/RCED-00-156. Improvements needed in overseeing the safety of dietary supplements and ‘functional foods’, Washington, DC, 2000. US Government
  • Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid (–)-epicatechin-3-gallate in the human intestinal cell line Caco-2. Journal of Pharmacology and Experimental Therapeutics 2003; 307: 745–752
  • Walgren RA, Lin J-T, Kinne RK-H, Walle T. Cellular uptake of dietary flavonoid quercetin 4′-ß-glucoside by sodium-dependent glucose transporter SGLT1. Journal of Pharmacology and Experimental Therapeutics 2000; 294: 837–843
  • Walle UK, Galijatovic A, Walle T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochemical Pharmacology 1999; 58: 431–438
  • Wiseman S, Mulder T, Rietveld A. Tea flavonoids: Bioavailability in vivo and effects on cell signaling pathway in vitro. Antioxidants and Redox Signaling 2001; 3: 1009–1021
  • Xu J, Go ML, Lim LY. Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: Lime, lemon, grapefruit, and pummelo. Pharmaceutical Research 2003; 20: 169–176
  • Yang CS, Chen L, Lee M-J, Balentine DA, Kuo MC, Schantz SP. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology, Biomarkers, and Prevention 1998; 7: 351–354
  • Yeh GC, Lopaczynska J, Poore CM, Phang JM. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Research 1992; 53: 5977–5981
  • Zhao F, Nozawa H, Daikonnya A, Kondo K, Kitanaka S. Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biological and Pharmaceutical Bulletin 2003; 26: 61–65
  • Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metabolism Reviews 2004; 36: 57–104

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.